Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Holding INSP?
Track your performance easily
INSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.00 - $257.40
Previous Close$187.77
Volume876.68K
Average Volume (3M)486.58K
Market Cap
$5.56B
Enterprise Value$5.17B
Total Cash (Recent Filing)$410.99M
Total Debt (Recent Filing)$25.22M
Price to Earnings (P/E)174.5
Beta0.84
Next Earnings
Feb 11, 2025EPS Estimate
$0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding29,966,914
10 Day Avg. Volume5,317,109
30 Day Avg. Volume486,583
Standard Deviation0.16
R-Squared0.18
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)8.08
Price to Sales (P/S)7.45
Price to Cash Flow (P/CF)26.90
P/FCF Ratio31.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.84
Enterprise Value/Gross Profit9.79
Enterprise Value/Ebitda134.06
Forecast
1Y Price Target
$239.80Price Target Upside27.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Inspire Medical Systems News
PremiumCompany Announcements
Inspire Medical Reports Strong Q3 Growth and Raises OutlookBulls Say, Bears Say
Bulls Say
Financial PerformanceINSP turns the corner on profitability and margin upside seems durable, positioning it firmly in the profitable growth category.
Market PositionDoctors continue to favor Inspire over Nyxoah and LivaNova, maintaining a stronghold on the commercial market despite emerging competitors.
Revenue And GrowthINSP's strongest quarter of profitability doubled management's FY24 EPS guidance and pushed FY25/26 EPS estimates higher, indicating robust future growth.
Bears Say
Financial PerformanceU.S. utilization in 3Q was flat sequentially vs. 2Q, and there is an expected modest year-over-year decline in U.S. utilization in 4Q24 based on INSP's updated FY24 guidance.
Market CompetitionCompetitor LIVN's OSPREY data in obstructive sleep apnea (OSA) showed similar AHI and ODI reductions to those seen in INSP's pivotal studies, but included patients with complete concentric collapse, potentially indicating a competitive advantage for LIVN.
Regulatory And Approval RisksThe upcoming approval of LLY's tirzepatide in obstructive sleep apnea could create commercial risk for INSP.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.00 and its highest was $257.40 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Currently, no data Available
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Feb 11, 2025 which is in 51 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Nov 04, 2024. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.061 by $0.539.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is $0.72.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,966,913 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.6 in its last earnings report, beating expectations of $0.061. Following the earnings report the stock price went up 3.264%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Among the largest hedge funds holding Inspire Medical Systems’s share is Gilder Gagnon Howe & Co LLC.. It holds Inspire Medical Systems’s shares valued at 47M.
---
Inspire Medical Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$239.80 (27.71% Upside)
$239.80 (27.71% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 305.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.74%
12-Months-Change
Fundamentals
Return on Equity
5.33%
Trailing 12-Months
Asset Growth
24.50%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
---
INSP Company Deck
---
INSP Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive outlook with significant revenue growth, profitability, and expansion, albeit with some minor challenges related to external factors like hurricanes and IV solution shortages impacting the fourth quarter.Read More>---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Month Forecast
Average Price Target
$239.80
▲(27.71% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
16/28 ratings generated profit
1 Year Average Return
+24.18%
assigned a buy rating 2 months ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +24.18% per trade.
---